$OMER
OMEROS CORP

2021 Q4 Form 10-K Financial Statement

#000155837022002582 Filed on March 01, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $0.00 $0.00 $10.63M
YoY Change -100.0% -100.0% -68.18%
Cost Of Revenue $0.00 $0.00 $90.00K
YoY Change -100.0% -100.0% -77.5%
Gross Profit $0.00 $0.00 $10.55M
YoY Change -100.0% -100.0% -68.05%
Gross Profit Margin 99.23%
Selling, General & Admin $54.84M $54.84M $17.90M
YoY Change 206.38% -24.56% 10.97%
% of Gross Profit 169.67%
Research & Development $118.8M $118.8M $26.46M
YoY Change 348.89% 10.37% -34.81%
% of Gross Profit 250.81%
Depreciation & Amortization $324.0K $1.386M $400.0K
YoY Change -19.0% -14.44% -24.53%
% of Gross Profit 3.79%
Operating Expenses $173.6M $118.8M $44.36M
YoY Change 291.38% 10.37% -21.79%
Operating Profit -$173.6M -$173.6M -$33.82M
YoY Change 413.42% 10.64% 42.66%
Interest Expense -$19.67M $19.67M -$7.990M
YoY Change 146.17% -26.47% 37.52%
% of Operating Profit
Other Income/Expense, Net $1.740M $1.740M $370.0K
YoY Change 370.27% 166.06% 27.59%
Pretax Income -$191.5M -$191.5M -$41.43M
YoY Change 362.34% -2.47% 41.74%
Income Tax $0.00 $0.00 -$4.160M
% Of Pretax Income
Net Earnings $194.2M $194.2M -$37.27M
YoY Change -621.11% -240.69% 27.54%
Net Earnings / Revenue -350.57%
Basic Earnings Per Share $3.12
Diluted Earnings Per Share $3.116M $3.12 -$604.4K
COMMON SHARES
Basic Shares Outstanding 62.54M 62.34M 61.65M
Diluted Shares Outstanding 62.34M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $157.3M $157.3M $135.0M
YoY Change 16.49% 16.49% 122.04%
Cash & Equivalents $100.8M $100.8M $10.50M
Short-Term Investments $56.46M $56.46M $124.5M
Other Short-Term Assets $8.216M $8.216M $11.10M
YoY Change -25.98% -25.98% 68.18%
Inventory $1.355M
Prepaid Expenses
Receivables $80.82M $80.82M $3.800M
Other Receivables $1.650M $1.650M $70.00K
Total Short-Term Assets $248.0M $248.0M $151.3M
YoY Change 63.9% 63.88% 45.82%
LONG-TERM ASSETS
Property, Plant & Equipment $30.01M $30.01M $28.10M
YoY Change 6.79% 6.79% 633.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.054M $1.054M $1.700M
YoY Change -38.0% -38.0% -26.09%
Total Long-Term Assets $171.3M $171.3M $29.76M
YoY Change 475.7% 476.81% -10.44%
TOTAL ASSETS
Total Short-Term Assets $248.0M $248.0M $151.3M
Total Long-Term Assets $171.3M $171.3M $29.76M
Total Assets $419.3M $419.3M $181.0M
YoY Change 131.59% 131.64% 32.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.40M $13.40M $4.199M
YoY Change 219.12% 219.05% -21.19%
Accrued Expenses $33.13M $38.39M $28.76M
YoY Change 15.23% 21.87% -38.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $648.0K $1.000M
YoY Change -35.2% -16.67%
Total Short-Term Liabilities $51.79M $51.79M $36.74M
YoY Change 40.98% 41.11% -33.76%
LONG-TERM LIABILITIES
Long-Term Debt $313.5M $313.5M $237.0M
YoY Change 32.26% 32.26% 48.31%
Other Long-Term Liabilities $30.24M $30.24M $28.00M
YoY Change 8.0% 8.0% -9.09%
Total Long-Term Liabilities $343.7M $343.7M $265.0M
YoY Change 29.7% 29.7% 39.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $51.79M $51.79M $36.74M
Total Long-Term Liabilities $343.7M $343.7M $265.0M
Total Liabilities $395.5M $395.5M $301.8M
YoY Change 31.04% 31.04% 22.68%
SHAREHOLDERS EQUITY
Retained Earnings -$683.1M -$872.7M
YoY Change -21.72% 18.79%
Common Stock $706.9M $751.9M
YoY Change -5.99% 20.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.78M $23.78M -$120.8M
YoY Change
Total Liabilities & Shareholders Equity $419.3M $419.3M $181.0M
YoY Change 131.59% 131.64% 32.18%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income $194.2M $194.2M -$37.27M
YoY Change -621.11% -240.69% 27.54%
Depreciation, Depletion And Amortization $324.0K $1.386M $400.0K
YoY Change -19.0% -14.44% -24.53%
Cash From Operating Activities -$18.21M -$109.7M -$18.41M
YoY Change -1.06% 9.63% -19.99%
INVESTING ACTIVITIES
Capital Expenditures -$74.00K $277.0K $0.00
YoY Change -2.12% -100.0%
Acquisitions
YoY Change
Other Investing Activities $112.5M $194.0M $7.990M
YoY Change 1307.91% -390.62% -120.37%
Cash From Investing Activities $112.4M $193.7M $8.000M
YoY Change 1305.23% -388.99% -120.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -810.0K 6.319M -170.0K
YoY Change 376.47% -96.38% -100.3%
NET CHANGE
Cash From Operating Activities -18.21M -109.7M -18.41M
Cash From Investing Activities 112.4M 193.7M 8.000M
Cash From Financing Activities -810.0K 6.319M -170.0K
Net Change In Cash 93.39M 90.31M -10.58M
YoY Change -982.73% 1117.57% 83.36%
FREE CASH FLOW
Cash From Operating Activities -$18.21M -$109.7M -$18.41M
Capital Expenditures -$74.00K $277.0K $0.00
Free Cash Flow -$18.14M -$110.0M -$18.41M
YoY Change -1.46% 9.59% -19.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
6.19
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.61
CY2019 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
1.27
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62344100
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57176743
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49523444
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.omeros.com/20211231#OperatingAndFinanceLeaseLiabilityCurrent
CY2021Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.omeros.com/20211231#OperatingAndFinanceLeaseLiabilityCurrent
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
181000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://www.omeros.com/20211231#OperatingAndFinanceLeaseLiabilityNoncurrent
CY2021Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://www.omeros.com/20211231#OperatingAndFinanceLeaseLiabilityNoncurrent
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001285819
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61671231
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62628855
CY2021 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-3.07
CY2020 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-3.02
CY2019 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-2.98
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.12
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.41
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.71
CY2021 omer Period Chargebacks Are Settled
PeriodChargebacksAreSettled
P28D
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.omeros.com/20211231#OperatingAndFinanceLeaseLiabilityCurrent
CY2020Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.omeros.com/20211231#OperatingAndFinanceLeaseLiabilityCurrent
CY2020Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://www.omeros.com/20211231#OperatingAndFinanceLeaseLiabilityNoncurrent
CY2020Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://www.omeros.com/20211231#OperatingAndFinanceLeaseLiabilityNoncurrent
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-34475
CY2021 dei Entity Registrant Name
EntityRegistrantName
OMEROS CORPORATION
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WA
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-1663741
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
201 Elliott Avenue West
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98119
CY2021 dei City Area Code
CityAreaCode
206
CY2021 dei Local Phone Number
LocalPhoneNumber
676-5000
CY2021 dei Security12b Title
Security12bTitle
Common Stock
CY2021 dei Trading Symbol
TradingSymbol
OMER
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10501000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
56458000
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
124452000
CY2021Q4 omer Contract Royalty Asset Current
ContractRoyaltyAssetCurrent
44319000
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
38155000
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
3841000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8149000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10455000
CY2020Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
2036000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
247889000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
151285000
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
886628577
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62726515
CY2021 dei Auditor Firm
AuditorFirmId
42
CY2021 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2021 dei Auditor Location
AuditorLocation
Seattle, Washington
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100808000
CY2021Q4 omer Contract Royalty Asset Noncurrent
ContractRoyaltyAssetNoncurrent
140251000
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1731000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
2551000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28276000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25526000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1054000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1055000
CY2021Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
67000
CY2020Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
625000
CY2021Q4 us-gaap Assets
Assets
419268000
CY2020Q4 us-gaap Assets
Assets
181042000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13400000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4199000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33134000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28755000
CY2021Q4 omer Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
5255000
CY2020Q4 omer Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
3782000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
51789000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
36736000
CY2021Q4 omer Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
29126000
CY2020Q4 omer Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
28770000
CY2021Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
313458000
CY2020Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
236288000
CY2021Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
1115000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62628855
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61671231
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
626000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
616000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
706288000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
751304000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-683134000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-872672000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
23780000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-120752000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
419268000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
181042000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
118775000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
107612000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
106324000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54842000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
49306000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39714000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
173617000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
156918000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
146038000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-173617000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-156918000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-146038000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-13374000
CY2021 us-gaap Interest Expense
InterestExpense
19669000
CY2020 us-gaap Interest Expense
InterestExpense
26751000
CY2019 us-gaap Interest Expense
InterestExpense
22657000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1740000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
654000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1553000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-191546000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-196389000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-167142000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-23256000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-19774000
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-191546000
CY2020 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-173133000
CY2019 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-147368000
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
385781000
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
35072000
CY2019 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
62882000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
194235000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-138061000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-84486000
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-3.07
CY2020 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-3.02
CY2019 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.98
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
6.19
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.61
CY2019 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
1.27
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.12
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.41
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.71
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62344100
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57176743
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49523444
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-100156000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
54238000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7598000
CY2019 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
13785000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-84486000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-109021000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
93675000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5022000
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
155000
CY2020 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
14770000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
61628000
CY2020 omer Adjustments To Additional Paid In Capital For Purchase Of Capped Calls
AdjustmentsToAdditionalPaidInCapitalForPurchaseOfCappedCalls
23223000
CY2020 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
-22073000
CY2020 omer Adjustments To Additional Paid In Capital For Termination Capped Call Contracts
AdjustmentsToAdditionalPaidInCapitalForTerminationCappedCallContracts
8387000
CY2020 omer Adjustments To Additional Paid In Capital For Tax Benefit Related To Issuance Of Convertible Senior Debt Net Of Extinguishment
AdjustmentsToAdditionalPaidInCapitalForTaxBenefitRelatedToIssuanceOfConvertibleSeniorDebtNetOfExtinguishment
12011000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-138061000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-120752000
CY2021 omer Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
8382000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
91000
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
241000
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
17539000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
194235000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
23780000
CY2021 us-gaap Profit Loss
ProfitLoss
194235000
CY2020 us-gaap Profit Loss
ProfitLoss
-138061000
CY2019 us-gaap Profit Loss
ProfitLoss
-84486000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
17630000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
14925000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
13785000
CY2021 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
310563000
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1696000
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
11649000
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
9232000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1386000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1616000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1790000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1310000
CY2021 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
14640000
CY2020 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-19736000
CY2019 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
13283000
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
668000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-109722000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-100086000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60073000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-13374000
CY2020 omer Deferred Income Taxes Excluding Discontinued Operations
DeferredIncomeTaxesExcludingDiscontinuedOperations
-12011000
CY2020 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-838000
CY2021 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
34314000
CY2020 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-31344000
CY2019 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
12367000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4900000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4024000
CY2021 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
125993000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
277000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
283000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
334000
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
32006000
CY2020 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
133194000
CY2019 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
58217000
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
100000000
CY2020 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
66446000
CY2019 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
55150000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
193710000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-67031000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3401000
CY2020 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
225030000
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6785000
CY2020 omer Payment For Purchase Of Capped Call
PaymentForPurchaseOfCappedCall
23223000
CY2020 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
125638000
CY2020 omer Proceeds From Termination Of Capped Call Contracts
ProceedsFromTerminationOfCappedCallContracts
7549000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
93675000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
54238000
CY2020 omer Increase Decrease In Restricted Investments
IncreaseDecreaseInRestrictedInvestments
-99000
CY2021 omer Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
8383000
CY2020 omer Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
5022000
CY2019 omer Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
7598000
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
241000
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1823000
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1195000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1139000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6319000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
174534000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
60697000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
90307000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7417000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2777000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10501000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3084000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5861000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100808000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10501000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3084000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
17876000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
11603000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
13462000
CY2021 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
289000
CY2020 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
216000
CY2019 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1440000
CY2021Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
157300000
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
38200000
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-191500000
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 10.8pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Significant items subject to such estimates include revenue recognition, OMIDRIA contract royalty asset valuation, stock-based compensation expense, and accruals for clinical trials and manufacturing of drug product. We base our estimates on historical experience and on various other factors, including the impact of the COVID-19 pandemic, that we believe are reasonable under the circumstances; however, actual results could differ from these estimates.</p>
CY2021Q4 omer Milestone Payment Receivable From Sale Of Royalty Under Asset Purchase Agreement
MilestonePaymentReceivableFromSaleOfRoyaltyUnderAssetPurchaseAgreement
200000000.0
CY2021 omer Maximum Period Product Allowed For Return
MaximumPeriodProductAllowedForReturn
P12M
CY2021 us-gaap Advertising Expense
AdvertisingExpense
7800000
CY2020 us-gaap Advertising Expense
AdvertisingExpense
5600000
CY2019 us-gaap Advertising Expense
AdvertisingExpense
8000000.0
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6651752
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9528915
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13604837
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
36505000
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
3771000
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1650000
CY2020Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
70000
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
38155000
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
3841000
CY2021Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
2000000.0
CY2020Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
1200000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100800000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10500000
CY2020 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
10764000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
10198000
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
9033000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
7647000
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1731000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
2551000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1400000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1600000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1800000
CY2020Q4 omer Accrued Contract Research Costs
AccruedContractResearchCosts
7952000
CY2021Q4 omer Accrued Sales Rebates Fees And Discounts Current
AccruedSalesRebatesFeesAndDiscountsCurrent
8442000
CY2020Q4 omer Accrued Sales Rebates Fees And Discounts Current
AccruedSalesRebatesFeesAndDiscountsCurrent
3326000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
7455000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5393000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
5172000
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
5205000
CY2021Q4 omer Accrued Contract Research Costs
AccruedContractResearchCosts
3916000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3706000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3948000
CY2021Q4 omer Accrued Clinical Trial Costs
AccruedClinicalTrialCosts
2430000
CY2020Q4 omer Accrued Clinical Trial Costs
AccruedClinicalTrialCosts
2121000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2013000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
810000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33134000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28755000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
320030000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
6572000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
313458000
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
320030000
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
77645000
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6097000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
236288000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25526000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1009000
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1822000
CY2021 omer Number Of Options To Extend Lease
NumberOfOptionsToExtendLease
2
CY2021 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
true
CY2021Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28276000
CY2021Q4 omer Lease Right Of Use Asset
LeaseRightOfUseAsset
29285000
CY2020Q4 omer Lease Right Of Use Asset
LeaseRightOfUseAsset
27348000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4607000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2740000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
648000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1042000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28811000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28032000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
315000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
738000
CY2021Q4 omer Lease Liability
LeaseLiability
34381000
CY2020Q4 omer Lease Liability
LeaseLiability
32552000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y10M24D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y9M18D
CY2021Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y8M12D
CY2020Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M24D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1281
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1285
CY2021Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.1270
CY2020Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.1185
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
7364000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
6055000
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1102000
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1367000
CY2020 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
295000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
3519000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
2893000
CY2021 us-gaap Sublease Income
SubleaseIncome
1776000
CY2020 us-gaap Sublease Income
SubleaseIncome
1300000
CY2021 us-gaap Lease Cost
LeaseCost
10390000
CY2020 us-gaap Lease Cost
LeaseCost
9310000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
10162000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
10103000
CY2021 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1171000
CY2020 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1490000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7118000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
702000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7276000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
274000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7438000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
71000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7508000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
7302000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
6264000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
42906000
CY2021Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1047000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
9488000
CY2021Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
84000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
33418000
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
963000
CY2021Q4 omer Operating Lease Early Termination Area Of Reduced Rentable Square Footage
OperatingLeaseEarlyTerminationAreaOfReducedRentableSquareFootage
13904
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
12.56
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
261000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
12348044
CY2021Q4 omer Long Term Purchase Commitment Termination Fee
LongTermPurchaseCommitmentTerminationFee
32000000.0
CY2021 omer Payment Of Technology Access Fees
PaymentOfTechnologyAccessFees
500000
CY2020 omer Payment Of Technology Access Fees
PaymentOfTechnologyAccessFees
5500000
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
19178539
CY2020Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6900000
CY2020Q3 us-gaap Share Price
SharePrice
14.50
CY2020Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
93700000
CY2019Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4400000
CY2019Q4 us-gaap Share Price
SharePrice
13.10
CY2019Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
54200000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.61
CY2021 omer Share Based Payment Arrangement Expense Continuing Operations
ShareBasedPaymentArrangementExpenseContinuingOperations
14945000
CY2020 omer Share Based Payment Arrangement Expense Continuing Operations
ShareBasedPaymentArrangementExpenseContinuingOperations
13777000
CY2019 omer Share Based Payment Arrangement Expense Continuing Operations
ShareBasedPaymentArrangementExpenseContinuingOperations
12967000
CY2021 omer Share Based Payment Arrangement Expense Discontinuing Operations
ShareBasedPaymentArrangementExpenseDiscontinuingOperations
2685000
CY2020 omer Share Based Payment Arrangement Expense Discontinuing Operations
ShareBasedPaymentArrangementExpenseDiscontinuingOperations
1148000
CY2019 omer Share Based Payment Arrangement Expense Discontinuing Operations
ShareBasedPaymentArrangementExpenseDiscontinuingOperations
818000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17630000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14925000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13785000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11938528
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.92
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2525525
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
15.34
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
921023
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.10
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
833143
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
14.85
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12709887
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M6D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y6M
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
261000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
9295395
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.00
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y6M
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
261000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-19472000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-16716000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-3784000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-3058000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-23256000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-19774000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-23256000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-19774000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-23300000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
300000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
700000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
143657000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
149993000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
66612000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
56103000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
11327000
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.007
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.008
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
102000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
113000
CY2021Q4 omer Deferred Tax Liabilities Gain On Discontinued Operation
DeferredTaxLiabilitiesGainOnDiscontinuedOperation
42212000
CY2020Q4 omer Deferred Tax Liabilities Equity Component Of Convertible Debt
DeferredTaxLiabilitiesEquityComponentOfConvertibleDebt
18302000
CY2021Q4 omer Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
6467000
CY2020Q4 omer Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
6197000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
48781000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
10586000
CY2021Q4 omer Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
9995000
CY2020Q4 omer Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
8646000
CY2020Q4 omer Deferred Tax Asset Disallowed Interest
DeferredTaxAssetDisallowedInterest
11859000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
17862000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
7411000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
249453000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
244598000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
24612000
CY2021Q4 omer Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
200672000
CY2020Q4 omer Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
219986000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
201340000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
219986000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
668000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2021Q4 omer Operating Loss Carryforwards Expiration
OperatingLossCarryforwardsExpiration
407700000
CY2021Q4 omer Operating Loss Carryforwards With No Expiration
OperatingLossCarryforwardsWithNoExpiration
251500000
CY2021 omer Deferred Tax Assets Valuation Allowance Percentage
DeferredTaxAssetsValuationAllowancePercentage
1
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-19300000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
37800000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.016
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.031
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.028
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.279
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.193
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.143
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.055
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.062
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.030
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.002
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.118
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.118
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.040
CY2021 omer Defined Contribution Plan Maximum Employer Matching Contribution
DefinedContributionPlanMaximumEmployerMatchingContribution
4000

Files In Submission

Name View Source Status
0001558370-22-002582-index-headers.html Edgar Link pending
0001558370-22-002582-index.html Edgar Link pending
0001558370-22-002582.txt Edgar Link pending
0001558370-22-002582-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
omer-20211231.xsd Edgar Link pending
omer-20211231x10k.htm Edgar Link pending
omer-20211231x10k006.jpg Edgar Link pending
omer-20211231x10k_htm.xml Edgar Link completed
omer-20211231xex10d1.htm Edgar Link pending
omer-20211231xex10d44.htm Edgar Link pending
omer-20211231xex23d1.htm Edgar Link pending
omer-20211231xex31d1.htm Edgar Link pending
omer-20211231xex31d2.htm Edgar Link pending
omer-20211231xex32d1.htm Edgar Link pending
omer-20211231xex32d2.htm Edgar Link pending
omer-20211231_cal.xml Edgar Link unprocessable
omer-20211231_def.xml Edgar Link unprocessable
omer-20211231_lab.xml Edgar Link unprocessable
omer-20211231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending